<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="74803">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02131831</url>
  </required_header>
  <id_info>
    <org_study_id>IDO 123 TRX</org_study_id>
    <nct_id>NCT02131831</nct_id>
  </id_info>
  <brief_title>Telomeres Parameters in Cirrhosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <brief_summary>
    <textblock>
      There are several factors that influence telomere length in patients with cirrhosis, such as
      metabolic derangements and infectious etiologies, The aim of the study is to compare
      telomere length and other parameters related to genetic instability in telomere/ telomerase
      system, in peripheral blood lymphocytes in cirrhosis from different etiologies.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>telomerase activity</measure>
    <time_frame>baseline</time_frame>
    <description>number of copies of telomerase in peripheral blood lymphocytes, as determined by FISH</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>cirrhosis</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with cirrhosis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cirrhotic patients from different etiologies

        Exclusion Criteria:

          -  decompensated cirrhosis (Child C)

          -  age under 18 years

          -  any known malignancy, including hepatocellular carcinoma

          -  patient that are unable to sign for informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ido Laish, MD</last_name>
    <email>ido.laish@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ido Laish, MD</last_name>
      <email>ido.laish@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <lastchanged_date>September 15, 2014</lastchanged_date>
  <firstreceived_date>April 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>ido laish</investigator_full_name>
    <investigator_title>phsician in gastroenterology institute</investigator_title>
  </responsible_party>
  <keyword>telomere</keyword>
  <keyword>telomerase</keyword>
  <keyword>cirrhosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
